331 related articles for article (PubMed ID: 32413354)
1. Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor
Nowak JK; Lindstrøm JC; Kalla R; Ricanek P; Halfvarson J; Satsangi J
Gastroenterology; 2020 Sep; 159(3):1151-1154.e2. PubMed ID: 32413354
[No Abstract] [Full Text] [Related]
2. Excessive anxiety in IBD patients is unnecessary for COVID-19.
Wang HG; Xie R; Ma TH; Yang XZ
Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):e121-e122. PubMed ID: 32409282
[No Abstract] [Full Text] [Related]
3. Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD.
Burgueño JF; Reich A; Hazime H; Quintero MA; Fernandez I; Fritsch J; Santander AM; Brito N; Damas OM; Deshpande A; Kerman DH; Zhang L; Gao Z; Ban Y; Wang L; Pignac-Kobinger J; Abreu MT
Inflamm Bowel Dis; 2020 May; 26(6):797-808. PubMed ID: 32333601
[TBL] [Abstract][Full Text] [Related]
4. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
[TBL] [Abstract][Full Text] [Related]
5. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors.
Rangel HR; Ortega JT; Maksoud S; Pujol FH; Serrano ML
Virus Res; 2020 Nov; 289():198154. PubMed ID: 32918944
[TBL] [Abstract][Full Text] [Related]
7. Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights Into COVID-19.
Wu C; Ye D; Mullick AE; Li Z; Danser AHJ; Daugherty A; Lu HS
Hypertension; 2020 Oct; 76(4):e29-e30. PubMed ID: 32673509
[No Abstract] [Full Text] [Related]
8. Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity.
Sakaguchi W; Kubota N; Shimizu T; Saruta J; Fuchida S; Kawata A; Yamamoto Y; Sugimoto M; Yakeishi M; Tsukinoki K
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825469
[TBL] [Abstract][Full Text] [Related]
9. ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients.
Ravaioli S; Tebaldi M; Fonzi E; Angeli D; Mazza M; Nicolini F; Lucchesi A; Fanini F; Pirini F; Tumedei MM; Cerchione C; Viale P; Sambri V; Martinelli G; Bravaccini S
Cell Transplant; 2020; 29():963689720968749. PubMed ID: 33108902
[TBL] [Abstract][Full Text] [Related]
10. Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells.
Lee S; Yoon GY; Myoung J; Kim SJ; Ahn DG
Emerg Microbes Infect; 2020 Dec; 9(1):2169-2179. PubMed ID: 32969768
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
Roehrich H; Yuan C; Hou JH
Cornea; 2020 Dec; 39(12):1556-1562. PubMed ID: 32826650
[TBL] [Abstract][Full Text] [Related]
12. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea.
Ma D; Chen CB; Jhanji V; Xu C; Yuan XL; Liang JJ; Huang Y; Cen LP; Ng TK
Eye (Lond); 2020 Jul; 34(7):1212-1219. PubMed ID: 32382146
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk.
Öztürk AB; Çağlayan B
Eur Ann Allergy Clin Immunol; 2020 Nov; 52(6):282-285. PubMed ID: 32914945
[No Abstract] [Full Text] [Related]
14. Single-cell expression profiles of
Lü M; Qiu L; Jia G; Guo R; Leng Q
Aging (Albany NY); 2020 Oct; 12(20):19880-19897. PubMed ID: 33104520
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know.
Dhawan R; Gundry RL; Brett-Major DM; Mahr C; Thiele GM; Lindsey ML; Anderson DR
J Mol Cell Cardiol; 2020 Jul; 144():12-14. PubMed ID: 32339565
[No Abstract] [Full Text] [Related]
17. Structural and functional modelling of SARS-CoV-2 entry in animal models.
Brooke GN; Prischi F
Sci Rep; 2020 Sep; 10(1):15917. PubMed ID: 32985513
[TBL] [Abstract][Full Text] [Related]
18. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19.
Dong M; Zhang J; Ma X; Tan J; Chen L; Liu S; Xin Y; Zhuang L
Biomed Pharmacother; 2020 Nov; 131():110678. PubMed ID: 32861070
[TBL] [Abstract][Full Text] [Related]
19. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.
Drak Alsibai K
Med Hypotheses; 2020 Oct; 143():109893. PubMed ID: 32512290
[TBL] [Abstract][Full Text] [Related]
20. ACE2 receptor expression in testes: implications in coronavirus disease 2019 pathogenesis†.
Verma S; Saksena S; Sadri-Ardekani H
Biol Reprod; 2020 Aug; 103(3):449-451. PubMed ID: 32427288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]